Sachin Badrinath Surade

Title: Inventor Sachin Badrinath Surade: Innovating in Antibody Research

Introduction

Sachin Badrinath Surade is a notable inventor based in Macquarie Park, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody therapies. With a total of 2 patents, Surade is recognized for his work that addresses critical medical challenges.

Latest Patents

Surade's latest patents include "Compositions and methods for anti-PACAP antibodies." This patent focuses on anti-PACAP antibodies, pharmaceutical compositions that comprise such antibodies, and methods for producing and utilizing these antibodies. Another significant patent is "Anti-PD-1 antibody-attenuated IL-2 immunoconjugates and uses thereof." This disclosure involves modified human interleukin-2 (hIL-2) proteins and human antibody molecules that specifically bind to human programmed cell death protein-1 (hPD-1), along with immunoconjugates that incorporate these elements.

Career Highlights

Sachin Badrinath Surade is currently employed at Cephalon, Inc., where he continues to advance his research in antibody development. His work is pivotal in creating therapies that can potentially improve patient outcomes in various diseases.

Collaborations

Surade collaborates with esteemed colleagues such as Julia Rozenfeld and Anthony Gerard Doyle. These partnerships enhance the innovative capacity of his research and contribute to the advancement of biotechnology.

Conclusion

In summary, Sachin Badrinath Surade is a prominent inventor whose work in antibody research is making a significant impact in the field of biotechnology. His patents reflect a commitment to developing innovative solutions for medical challenges.